Department of Pharmaceutical Research

Aims and Scope

The Department of Pharmaceutical Research of The Gazette of Medical Sciences (The GMS) is dedicated to advancing the scientific foundations of medicines, from the identification of promising therapeutic compounds to their formulation, characterization, evaluation and development. Its editorial focus brings together pharmaceutical chemistry, pharmaceutics, biopharmaceutics, pharmaceutical analysis and translational drug research. The Department particularly values mechanism-based, hypothesis-driven investigations that address meaningful challenges in the discovery, development, quality, safety and regulatory assessment of pharmaceutical products.

Drug discovery and preclinical development form a central part of the Department's scope. Contributions may investigate small-molecule therapeutics, natural products, molecular targets, structure–activity relationships, medicinal chemistry, lead optimization, drug–receptor interactions, pharmacodynamics and pharmaceutical toxicology. Experimental and computational investigations, including molecular docking, molecular dynamics, quantitative structure–activity relationships and in-vitro or in-vivo evaluation, are encouraged when supported by scientifically appropriate methods and interpretations. The Department welcomes both positive and rigorously documented negative findings that advance pharmaceutical knowledge.

A further priority is the design and evaluation of drug formulations and delivery systems. Research may address pharmaceutical solid materials, biomaterials, polymers, nanoparticles, liposomes, hydrogels, controlled-release formulations, targeted drug delivery, solubility enhancement, dissolution, stability and pharmaceutical manufacturing processes. Studies exploring the relationships between physicochemical properties, dosage-form performance, drug absorption, bioavailability, pharmacokinetics, metabolism and disposition are especially relevant. Computational and molecular biopharmaceutics are included where they contribute to understanding or improving drug-product performance.

The Department also considers biotechnology-derived pharmaceutical products, including therapeutic peptides, proteins, monoclonal antibodies, vaccines, gene-based therapies and genetically engineered cell products. Research in pharmacogenomics, personalized pharmaceutical treatment, pharmacokinetic modeling, pharmaceutical biotechnology and translational therapeutics is welcomed. Contributions involving pharmacognosy, medicinal plants, phytochemical characterization and natural-product formulations should provide appropriate analytical, mechanistic or experimental evidence rather than relying solely on traditional claims of therapeutic benefit.

Pharmaceutical quality, analytical reliability and responsible development are integral to the Department's mission. Submissions may examine analytical method development and validation, chromatographic and spectroscopic techniques, impurity profiling, stability-indicating assays, quality by design, process analytical technology, pharmaceutical manufacturing, regulatory science and drug-product evaluation. The Department publishes original research articles, reviews, case studies, short communications, letters, editorials, scholarly perspectives and appropriately reviewed thematic contributions. Interdisciplinary work connecting pharmaceutical sciences with clinical medicine, chemistry, engineering, computational science and public health is encouraged, with particular attention to reproducibility, research ethics and the responsible translation of pharmaceutical discoveries.

Areas of Interest

• Small-Molecule Drug Discovery
• Pharmaceutical Solid Materials
• Pharmaceutical Biomaterials
• Pharmaceutical Polymers
• Pharmaceutical Nanoparticles
• Biotechnology-Derived Medicines
• Therapeutic Genes and Gene Products
• Therapeutic Peptides and Proteins
• Vaccines and Biological Products
• Genetically Engineered Cell Therapies
• Pharmacodynamics
• Pharmacokinetics
• Pharmaceutical Toxicology
• Pharmacogenomics
• Pharmaceutics
• Pharmacognosy
• Drug Delivery and Targeting
• Drug Metabolism
• Drug Disposition
• Computational Biopharmaceutics
• Molecular Biopharmaceutics
• Medicinal Chemistry
• Pharmaceutical Chemistry
• Lead Identification and Optimization
• Structure–Activity Relationships
• Drug–Receptor Interactions
• Molecular Docking
• Molecular Dynamics Simulation
• Computer-Aided Drug Design
• Natural-Product Drug Discovery
• Phytochemistry
• Medicinal Plant Extracts
• Preclinical Drug Evaluation
• In-Vitro Pharmaceutical Studies
• In-Vivo Pharmaceutical Studies
• Drug Formulation Development
• Novel Drug Delivery Systems
• Targeted Drug Delivery
• Controlled and Sustained Release
• Liposomal Drug Delivery
• Polymeric Drug Carriers
• Nanomedicine
• Solubility Enhancement
• Dissolution and Drug Release
• Bioavailability and Bioequivalence
• Biopharmaceutics
• Pharmaceutical Excipients
• Tablet and Capsule Technology
• Injectable Formulations
• Transdermal Drug Delivery
• Oral Drug Delivery
• Pharmaceutical Stability Studies
• Pharmaceutical Analysis
• Analytical Method Development
• Analytical Method Validation
• Chromatographic Analysis
• HPLC and UPLC Methods
• Spectroscopic Drug Analysis
• Mass Spectrometry
• Impurity and Degradation Profiling
• Stability-Indicating Methods
• Quality by Design
• Pharmaceutical Quality Control
• Pharmaceutical Manufacturing
• Process Analytical Technology
• Pharmaceutical Biotechnology
• Biologics and Biosimilars
• Pharmaceutical Regulatory Science
• Drug Development and Evaluation
• Translational Pharmaceutical Research

The Department encourages submissions that contribute substantive experimental, analytical, computational or translational insights to pharmaceutical science. Editorial decisions are guided by scientific merit, methodological rigor, ethical compliance and relevance to the Department's scope.